120514 cases Flashcards
(48 cards)
how to differentiate reactive vs neoplastic LAD
duration? growth interval (rapid?)?
size? (1 cm is way too big)
location? (axilla, cervical, inguinal-if not these, then probably more concerning)
tender vs nontender? (tender means probably acute and infectious. nontender suggests more neoplastic)
fixed vs. mobile? (fixed is more concerning)
associated PE findings?
how to differentiate reactive vs neoplastic LAD with histology
LN architecture is intact or effaced (effaced suggests neoplastic)
dominant cell type? (heterogeneous in reactive LAD-has dark/light zones of germinal center)
atypia?
flow cytometry?
reactive causes of LAD?
infectious
autoimmune
drugs (phenytoin)
foreign body
LAD-neoplastic causes of it?
lymphoma
leukemic involvement
metastatic tumor
histologic patterns of reactive LAD
follicular hyperplasia (autoimmune, early HIV, toxoplasmosis)
paracortical hyperplasia (EBV, CMV, herpes, drugs)
sinus histiocytosis (draining tumors)
which non Hodgkin’s lymphomas are aggressive?
Burkitt
diffuse large B cell
mantle cell (moderate)
peripheral T cell, unspecified
anaplastic large cell
extranodal NK/T cell
Hodgkin’s lymphoma’s spread–what is important to note about it?
contiguous
tx for follicular lymphoma
chemotherapy and antiCD20 monoclonal antibody therapy
starry sky-what is it exactly?
sky is sea of tumor cells
starry part is the tingible body macrophages that eat the debris as cells turnover
starry sky is seen in
Burkitt lymphoma
t(11;14)
cyclin D1 gene (chromosome 11) translocates to Ig heavy chain gene on chromosome 14
t(11;14) is associated with
mantle cell lymphoma
CD5 positive
mantle cell lymphoma
t(14,18)
BCL2 gene translocates to Ig heavy chain gene on chromsome 14
BCL2 overexpression
follicular lymphoma
CD30+ and CD15+
Hodgkin’s lymphoma
Burkitt lymphoma immunophenotype
CD10+
CD19+
CD20+
extranodal marginal zone lymphoma (MALToma) immunophenotype
CD5-
CD10-
CD19+
CD20+
follicular lymphoma immunophenotype
CD5-
CD10+
CD19+
CD20+
mantle cell lymphoma immunophenotype
CD5+
CD10-
CD19+
CD20+
MOA of rituximab
for therapy in FL–has improved survival for this disease
CDC
ADCC
apoptosis
ionizing radiation induced cell death
course of follicular lymphoma
generally indolent
however 40% can turn into aggressive lymphomas (diffus large B cell lymphoma, Burkitt lymphoma)
what can cause Burkitt lymphoma?
EBV
diagnosing B cell non Hodgkin’s lymphoma-what should you consider?
architecture-nodular, follicular or diffuse?
tumor cells–are they small, medium, large? are they clefted/cleaved (FOLLICULAR LYMPHOMA), mantle, or marginal zone?
immunophenotype:
establish it’s B cell
small size lymphomas-CD5, CD10, CD23
cytogenetics:
t(14;18)–BCL2
t(11;14)–cyclinD1
t(8;14)–cMyc